Tenon Medical, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
Stock price today
Loading chart…
Third-party market data · may be delayed
Model estimate per share
Not valued: the figures our models need are missing or failed our data-quality checks.
Price vs value
No model value: limited reported history: available models are shown without a Buy/Hold/Sell rating. How we value companies.
Tenon Medical, Inc. valuation: adjust assumptions and compare models →
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Insiders4 buying, 1 selling12 purchases and 9 sales by directors and officers, last 12 monthsInsider trades
The Fundamentalytics view
Current signal Results well short of expectations: Reported earnings per share missed the analysts' consensus estimate by 47% in the quarter to 2026-06-30.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
Nothing in Tenon Medical, Inc.'s latest figures clears our strength thresholds.
Things to watch
- Results due soon. Results are expected around 16 November; the share price can move sharply on the day.
- Volatile shares. Over the past year the shares showed annualised volatility of 220% and a beta of 0.8 against the S&P 500.
- Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.
Latest results
- Earnings per share
- -$12.35 against an average estimate of -$8.40: missed by 47.0%
- Share reaction
- -8.5% in the first session after the results on August 13, 2026, against +0.5% for the S&P 500
- Next report
- November 12, 2026; average EPS estimate -$4.22
Price chart
- 1 day-5.9%
- 1 week-10.4%
- 1 month-47.8%
- This year-94.2%
- 1 year-95.4%
- S&P 500 this year+11.2%
Loading chart…
Third-party market data · may be delayed
At a glance
Earnings
- Last results
- August 13, 2026
- Next results (est.)
- November 16, 2026
News & updates
Company announcements, filed results and changes that matter to shareholders.
- AgreementSEC 8-KRead source ↗
- Agreement
Tenon Medical, Inc. entered a material agreement; sold unregistered shares; disclosed a material event
SEC 8-KRead source ↗ - Announcement
Tenon Medical, Inc. disclosed a material event
SEC 8-KRead source ↗ - Agreement
Tenon Medical, Inc. entered a material agreement; sold unregistered shares; disclosed a material event
SEC 8-KRead source ↗ - Announcement
Tenon Medical, Inc. disclosed a material event
SEC 8-KRead source ↗ - Results
Tenon Medical, Inc. reported results
SEC 8-KRead source ↗ - Announcement
Tenon Medical, Inc. amended its charter or bylaws; made a public disclosure
SEC 8-KRead source ↗ - Shareholder vote
Tenon Medical, Inc. reported shareholder vote results
SEC 8-KRead source ↗ - Announcement
Tenon Medical, Inc. disclosed a material event
SEC 8-KRead source ↗ - Announcement
Tenon Medical, Inc. disclosed a material event
SEC 8-KRead source ↗
Valuation models
We value Tenon Medical, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.93 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | — | No model applies: the filings don’t yet support a value. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Tenon Medical, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Forecasts and guidance
Next results: November 12, 2026, after the close. Analysts expect revenue of $2m and EPS of −$4.22 (range −$5.62 to −$2.83) for the quarter.
Analysts' consensus
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | −$17.41 | +71% | $6m | +53% |
| Next | −$4.87 | +72% | $9m | +47% |
How the EPS forecast has moved
The consensus EPS forecast for the current fiscal year is −41.1% on 90 days ago. In the last 30 days, 1 analyst raised Tenon Medical, Inc.'s forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
View chart data
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | −$29.58 | −$21.18 |
| 60 days ago | −$21.25 | −$12.02 |
| 30 days ago | −$21.25 | −$12.02 |
| 7 days ago | −$21.25 | −$12.02 |
| Now | −$17.41 | −$4.87 |
Earnings against estimates
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$8.40 | −$12.35 | −47.0% |
| Mar 2026 | −$10.68 | −$10.85 | −1.6% |
| Dec 2025 | −$12.60 | −$7.70 | +38.9% |
| Sept 2025 | −$12.95 | −$14.00 | −8.1% |
Adjusted EPS as companies report it, against the average analyst estimate.
Positioning
- Short interest
- 2.0% of tradable shares
- Days to cover
- 0.01 at average volume
- Short interest, 1 month
- −90% to October 15, 2026
- Held by institutions
- 2% of shares
- Held by insiders
- 2.2% of shares
- Employees
- 26 full time
Share-price performance
Market data may be delayedReturn and risk by year
| Calendar year | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|
| Return | ||||
| TNON | −90% | −85% | −49% | −94% |
| Industry peers (median) | −8% | −19% | −16% | −13% |
| S&P 500 | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||
| TNON | 42% | 8% | 33% | 9% |
| S&P 500 | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||
| TNON | −97% | −86% | −77% | −95% |
| S&P 500 | −10% | −8% | −19% | −9% |
Worst fall since April 27, 2022: 100% from May 9, 2022 to November 2, 2026. Getting back needed a 7224771% gain, and the shares have not yet recovered.
Price behaviour
- 52-week range
- $1.93 – $45.15
- From 52-week high
- −95.7%
- vs 50-day average
- −46.0%
- vs 200-day average
- −88.6%
- Volatility (1 year)
- 220%
- Beta vs S&P 500
- 0.81
Share price after results
- Next day
- 2 up, 4 down typical move ±8.3%
- After a week
- 2 up, 4 down typical move ±15.7%
- After a month
- 1 up, 5 down typical move ±16.2%
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| August 13, 2026 | −8.5% | +0.5% | +25.4% | −1.4% |
| May 12, 2026 | −8.9% | +0.4% | −11.4% | −21.1% |
| March 19, 2026 | −3.3% | −1.7% | −11.6% | −3.9% |
| February 6, 2026 | +23.1% | +2.4% | +11.0% | +18.9% |
| March 14, 2024 | +1.8% | −0.9% | −6.3% | −35.2% |
| June 7, 2022 | −4.2% | −0.1% | −28.3% | −17.0% |
Fundamentals
Insider trading activity
Full insider history and chart| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Hrt Financial Lp 10% owner | September 10, 2026 | Buy | 31,227 | $2.92 | $91,183 |
| Hrt Financial Lp 10% owner | September 10, 2026 | Buy | 28,267 | $4.02 | $113,633 |
| Hrt Financial Lp 10% owner | September 10, 2026 | Buy | 8,431 | $4.92 | $41,481 |
| Hrt Financial Lp 10% owner | September 10, 2026 | Sell | 65,582 | $5.56 | $364,636 |
| Hrt Financial Lp 10% owner | September 9, 2026 | Sell | 9,948 | $4.27 | $42,478 |
| Hrt Financial Lp 10% owner | September 9, 2026 | Buy | 39,508 | $3.40 | $134,327 |
| Hrt Financial Lp 10% owner | September 9, 2026 | Sell | 50,395 | $2.61 | $131,531 |
| Hrt Financial Lp 10% owner | September 8, 2026 | Buy | 707 | $3.34 | $2,361 |
| Hrt Financial Lp 10% owner | September 4, 2026 | Sell | 1,506 | $3.70 | $5,572 |
| Hrt Financial Lp 10% owner | September 3, 2026 | Buy | 1,658 | $3.98 | $6,599 |
| Hrt Financial Lp 10% owner | September 2, 2026 | Sell | 450 | $4.53 | $2,038 |
| Hrt Financial Lp 10% owner | September 1, 2026 | Buy | 1,790 | $4.57 | $8,180 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
Next expected around November 16, 2026 estimated from the company's past filing pattern, not announced
- August 13, 2026
- May 12, 2026
- March 19, 2026
- February 6, 2026
- March 14, 2024
- June 7, 2022
Recent SEC filings
- 8-K Current report
- S-3 REGISTRATION STATEMENT
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Tenon Medical, Inc. in brief
- What does Tenon Medical, Inc. do?
- Tenon Medical, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
- What is Tenon Medical, Inc.'s stock ticker?
- Tenon Medical, Inc. trades under the ticker TNON on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
- Are insiders buying or selling Tenon Medical, Inc. stock?
- Over the last 12 months, Tenon Medical, Inc.'s directors and officers reported 12 open-market purchases and 9 sales on Form 4. The insider trading page charts every trade.
- When is Tenon Medical, Inc.'s next earnings date?
- Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Tenon Medical, Inc. announces its own schedule.
Follow research on Tenon Medical, Inc.
New research on the companies we cover arrives in the weekly email. Free, one email a week.